Page last updated: 2024-08-21

thiazoles and Torsade de Pointes

thiazoles has been researched along with Torsade de Pointes in 10 studies

Research

Studies (10)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's6 (60.00)29.6817
2010's3 (30.00)24.3611
2020's1 (10.00)2.80

Authors

AuthorsStudies
Chiba, K; Goto, A; Hagiwara-Nagasawa, M; Izumi-Nakaseko, H; Kambayashi, R; Matsumoto, A; Naito, AT; Sugiyama, A1
Alipour, A; Cruz, R; Lott, RS1
Correll, CU; Figen, V; Kane, JM; Lops, JD; Malhotra, AK; Manu, P1
Nielsen, J1
Taylor, D1
Martel, ML1
Citrome, L; Volavka, J1
Finzel, M; Fric, M; Laux, G1
Brown, FW; Greco, KE; Tune, LE; Van Horn, WA1
Hoffman, RS; Manini, AF; Nelson, LS; Raspberry, D1

Reviews

2 review(s) available for thiazoles and Torsade de Pointes

ArticleYear
Ziprasidone in the management of schizophrenia : the QT interval issue in context.
    CNS drugs, 2003, Volume: 17, Issue:6

    Topics: Antipsychotic Agents; Electrocardiography; Female; Humans; Long QT Syndrome; Male; Piperazines; Risk Assessment; Risk Factors; Schizophrenia; Sex Factors; Thiazoles; Torsades de Pointes

2003
The promise of atypical antipsychotics: fewer side effects mean enhanced compliance and improved functioning.
    Postgraduate medicine, 2004, Volume: 116, Issue:4

    Topics: Antipsychotic Agents; Aripiprazole; Benzodiazepines; Clozapine; Diabetes Mellitus, Type 2; Dibenzothiazepines; Drug Administration Schedule; Humans; Hyperprolactinemia; Mental Disorders; Olanzapine; Patient Compliance; Piperazines; Practice Guidelines as Topic; Prescription Fees; Quetiapine Fumarate; Quinolones; Risk Assessment; Risperidone; Thiazoles; Torsades de Pointes; Treatment Outcome; Weight Gain

2004

Trials

1 trial(s) available for thiazoles and Torsade de Pointes

ArticleYear
[QTc-interval prolongation in therapy with atypical antipsychotics--results of an open, non-randomized survey].
    Psychiatrische Praxis, 2004, Volume: 31 Suppl 1

    Topics: Antipsychotic Agents; Electrocardiography; Germany; Hospitalization; Hospitals, Psychiatric; Humans; Long QT Syndrome; Piperazines; Prospective Studies; Psychotic Disorders; Risk Assessment; Thiazoles; Torsades de Pointes

2004

Other Studies

7 other study(ies) available for thiazoles and Torsade de Pointes

ArticleYear
Experimental analysis of the onset mechanism of TdP reported in an LQT3 patient during pharmacological treatment with serotonin-dopamine antagonists against insomnia and nocturnal delirium.
    Heart and vessels, 2020, Volume: 35, Issue:4

    Topics: Action Potentials; Anesthetics, Inhalation; Animals; Calcium Channel Agonists; Cardiac Conduction System Disease; Delirium; Dogs; Dopamine Antagonists; Dose-Response Relationship, Drug; Electrocardiography; Female; Halothane; Heart Conduction System; Humans; Isoindoles; Long QT Syndrome; Middle Aged; Models, Animal; Piperazines; Piperidines; Potassium Channel Blockers; Serotonin Antagonists; Sleep Initiation and Maintenance Disorders; Thiazoles; Torsades de Pointes

2020
Torsade de pointes after ziprasidone overdose with coingestants.
    Journal of clinical psychopharmacology, 2010, Volume: 30, Issue:1

    Topics: Antidepressive Agents, Second-Generation; Antipsychotic Agents; Anxiety Disorders; Bipolar Disorder; Drug Overdose; Female; Humans; Long QT Syndrome; Middle Aged; Piperazines; Thiazoles; Torsades de Pointes

2010
QT interval duration and dispersion in children and adolescents treated with ziprasidone.
    The Journal of clinical psychiatry, 2011, Volume: 72, Issue:6

    Topics: Adolescent; Antipsychotic Agents; Child; Dose-Response Relationship, Drug; Electrocardiography; Female; Heart Rate; Humans; Long QT Syndrome; Male; Piperazines; Potassium; Thiazoles; Torsades de Pointes

2011
The safety of atypical antipsychotics: does QTc provide all the answers?
    Expert opinion on drug safety, 2011, Volume: 10, Issue:3

    Topics: Antipsychotic Agents; Humans; Long QT Syndrome; Piperazines; Thiazoles; Torsades de Pointes

2011
Ziprasidone for sedation of the agitated ED patient.
    The American journal of emergency medicine, 2004, Volume: 22, Issue:3

    Topics: Antipsychotic Agents; Droperidol; Drug Labeling; Emergency Treatment; Humans; Long QT Syndrome; Piperazines; Practice Guidelines as Topic; Psychomotor Agitation; Thiazoles; Torsades de Pointes; United States; United States Food and Drug Administration

2004
A retrospective study of the safety of intramuscular ziprasidone in agitated elderly patients.
    The Journal of clinical psychiatry, 2005, Volume: 66, Issue:7

    Topics: Aged; Aged, 80 and over; Antipsychotic Agents; Arrhythmias, Cardiac; Dementia; Electrocardiography; Female; Haloperidol; Humans; Injections, Intramuscular; Long QT Syndrome; Male; Middle Aged; Piperazines; Psychomotor Agitation; Retrospective Studies; Risk Factors; Thiazoles; Torsades de Pointes

2005
QT prolongation and Torsades de Pointes following overdose of ziprasidone and amantadine.
    Journal of medical toxicology : official journal of the American College of Medical Toxicology, 2007, Volume: 3, Issue:4

    Topics: Adult; Amantadine; Analgesics, Non-Narcotic; Antipsychotic Agents; Drug Overdose; Drug Therapy, Combination; Electrocardiography; Fatal Outcome; Female; Humans; Ibuprofen; Long QT Syndrome; Piperazines; Suicide, Attempted; Thiazoles; Torsades de Pointes

2007